Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of July 2020, with a specific reporting date of July 10, 2020. The document serves as a transaction notification regarding dealings in the company's ordinary shares by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) with them.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. It exclusively details specific share transactions executed on July 9, 2020, on the London Stock Exchange (XLON).
| Transaction Type | Instrument | Price per Share | Total Volume |
|---|---|---|---|
| Acquisition (Dividend Re-investment) | Ordinary Shares (25p each) | £16.1054 | 1,381 shares |
Note: The total volume of 1,381 shares is the aggregate of individual transactions listed in the filing (11 + 4 + 1 + 29 + 883 + 455).
Material Changes
The filing does not report material changes to the company's financial position, operations, or strategy compared to prior periods. It strictly documents routine compliance disclosures for share acquisitions resulting from dividend re-investment plans.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, risk factors, or contingencies. The transactions were executed as part of a dividend re-investment program paid to shareholders on July 9, 2020.
Key Facts for Investor Verification
- Transaction Nature: All reported transactions were acquisitions of ordinary shares via dividend re-investment, not open market purchases or sales.
- Participants: Transactions involved senior executives including Mr. N. Hirons (SVP, Global Ethics & Compliance), Ms. S. Jackson (SVP, Global Communications & CEO Office), Ms. V. Whyte (Company Secretary), and their associated persons.
- Market Data: The share price at the time of transaction was £16.1054.
- Financial Data Absence: Investors should refer to GSK's Form 20-F or interim financial reports for revenue, earnings, and cash flow data, as this Form 6-K contains none.